Related Experiment Video
Updated: Aug 19, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Priority in the pharmacological management of chronic schizophrenia: the quality of life issues
Abstract:
The progress of pharmacological management of schizophrenia is briefly reviewed, highlighting some of the major limitations especially in regard to side-effects which have been identified. The importance of the quality of life issues in chronic patients undergoing pharmacological treatment is stressed. A possible new approach is the use of beta-adrenergic blocking drugs which may have symptomatic effects as well as quality of life effects.
More Related Videos
04:33Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Schizophrenia
Drug Therapy
Antianxiety Medications